You are here
Side effects of TKI therapies
Many changes take place in your body after starting treatment for CML. There are a variety of common and less common side effects from TKI therapy, especially within the first three months.
The physical side effects you may have from TKI therapy fall into common, less common and rare or very rare categories. It depends largely on the individual, their own health and physiology as well as any co-morbidities (other health conditions) they may have.
The following manufacture's websites provide detailed information about each of the five TKI oral therapies currently available.
-
imatinib (Glivec®) – www.novartisoncology.com/products/glivec.jsp
-
nilotinib (Tasigna®) - www.tasigna.com
-
dasatinib (Sprycel®) - www.sprycel.com
-
bosutinib (Bosulif®) - www.pfizermedicalinformation.com/en-us/bosulif
-
ponatinib (Iclusig®) - http://www.incyte.com/iclusig